CytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer Program

Stock Information for Citius Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Citius Pharmaceuticals Inc.

CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb(TM)-ATR
CytoSorbents to Participate at the Jefferies Global Healthcare Conference
CytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025
CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update
CytoSorbents Provides Regulatory Update for DrugSorb-ATR
CytoSorbents to Report First Quarter 2025 Financial Results and Recent Business Highlights
CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller
CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.